<DOC>
	<DOCNO>NCT00189462</DOCNO>
	<brief_summary>The objective pilot study evaluate efficacy treatment montelukast compare placebo prevention recurrence acute Otitis medium ( AOM )</brief_summary>
	<brief_title>A Pilot Study Evaluate Efficacy Montelukast Treatment Acute Otitis Media ( AOM ) Children</brief_title>
	<detailed_description>Otitis medium ( OM ) one common childhood disorder require physician care associate alarm rise prevalence . Certain child prone recurrent episode acute Otitis medium ( RAOM ) and/or development chronic Otitis medium effusion ( COME ) . Because medical therapy antibiotic , antihistamine , decongestant corticosteroid demonstrable efficacy , mainstay treatment surgical intervention , quite expensive expose patient risk general anesthesia . The objective pilot study evaluate efficacy treatment montelukast compare placebo prevention recurrence acute Otitis medium ( AOM )</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Aged 18 month 5 year old . Diagnosis current AOM Presence primary secondary immunodeficiency , craniofacial abnormality , cleft palate , anatomic predisposition , major congenital anomaly syndrome , severe systemic disease Use : Any investigational medication within past 30 day , systemic oral nasal steroid within past 30 day Accolate® past 7 day Antibiotics within past week , except Zithromax® , 21 day Long act second generation antihistamine ( i.e. , Claritin® , Clarinex® , Allegra® Zyrtec® ) within past 72 hour . No know allergy either montelukast amoxicillin/clavulanate Have respond Augmentin® past</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Ear Infections</keyword>
	<keyword>Otitis Media</keyword>
</DOC>